Aerosolized ribavirin treatment of infants with respiratory syncytial viral infection. A randomized double-blind study

Clicks: 347
ID: 121287
1983
Free PDF
Article Quality & Performance Metrics
Overall Quality Improving Quality
0.0 /100
Combines engagement data with AI-assessed academic quality
AI Quality Assessment
Not analyzed
Abstract
We evaluated a new antiviral agent, ribavirin, in the treatment of infants hospitalized with lower-respiratory-tract disease from respiratory syncytial virus. Ribavirin or placebo was administered to 33 infants in a double-blind manner by continuous aerosol for three to six days. Seventeen infants w …
Reference Key
cb1983theaerosolized Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors Hall CB;McBride JT;Walsh EE;Bell DM;Gala CL;Hildreth S;Ten Eyck LG;Hall WJ;;
Journal The New England journal of medicine
Year 1983
DOI
DOI not found
URL
http://www.ncbi.nlm.nih.gov/pubmed/6343860
Keywords
National Center for Biotechnology Information NCBI NLM MEDLINE clinical trials as topic humans pubmed abstract nih national institutes of health national library of medicine research support non-u.s. gov't u.s. gov't female male Child Infant newborn P.H.S. preschool Clinical Trial Randomized Controlled Trial Double-Blind Method Random Allocation respiratory syncytial viruses / isolation & purification c b hall aerosols respiratory tract infections / drug therapy* respirovirus infections / drug therapy* ribavirin / administration & dosage* antiviral agents / administration & dosage* j t mcbride ribonucleosides / administration & dosage* pmid:6343860 doi:10.1056/nejm198306163082403 w j hall

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

Comments

No comments yet. Be the first to comment on this article.